Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 60Years
All Genders
ID06801522

Comparison of the Efficacy of Adrenaline Nasal Pack and Xylometazoline Nasal Drops in Decreasing Nasal Bleeding During Nasotracheal Intubation

Led by Shaheed Mohtarma Benazir Bhutto Institue of Trauma · Updated on 2025-01-30

70

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are comparing the effects of xylometazoline nasal drops and adrenaline nasal packing on nasal bleeding during nasotracheal intubation in participants undergoing elective oromaxillofacial surgeries. The trial aims to determine which of these two treatments better reduces nasal bleeding during the procedure. This study includes participants aged 18 to 60 years with specific health criteria to ensure safety and accuracy. Participants are randomly assigned to one of two groups. One group receives 0.1% xylometazoline nasal drops, administered as 3 to 5 drops in the selected nostril 15 minutes before surgery. The other group receives adrenaline nasal packing, where a gauze soaked in adrenaline is placed inside the nostril 15 minutes before surgery and removed after 7 to 10 minutes. Both groups undergo nasotracheal intubation under general anesthesia with careful monitoring. Throughout the study, participants will have vital signs monitored, including blood pressure, heart rate, ECG, and oxygen saturation. An experienced anesthesiologist will perform the procedures and record the incidence and severity of nasal bleeding during intubation and extubation. Data will be analyzed to compare bleeding outcomes between groups while considering factors like age, gender, and medical history. Participation lasts through the surgical procedure and immediate recovery monitoring.

CONDITIONS

Brief Title

Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • ASA physical status 1 and 2
  • Age between 18 and 60 years
  • Mallampati score 1 or 2
  • Any gender
  • Scheduled for elective oromaxillofacial surgery
Not Eligible

You will not qualify if you...

  • Lack of consent
  • Anticipated difficult airway
  • Receiving anticoagulant therapy
  • History of nasal surgery, trauma, polyp, or obstruction
  • History of repeated nosebleeds
  • Uncontrolled hypertension, diabetes, pregnancy, or cardiac or cerebral events history

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single day on surgery day

Participants receive either xylometazoline nasal drops or adrenaline nasal packing before nasotracheal intubation during elective oromaxillofacial surgery under general anesthesia.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Shaheed Mohtarma Benazir Bhutto Institute of Trauma

Karachi, Sindh, Pakistan

Actively Recruiting

Loading map...

Research Team

D

Dr Sidra Javed Consultant Anaesthetist, MBBS, FCPS, PAIN FELLOW

D

Dr Mirza Shahzad Baig Consultant Anaesthetist, MBBS, MCPS, FCPS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

The Effect of Nostril Side on Epistaxis During Nasotracheal ...

Nasotracheal Intubation

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison of hemostatic effect and safety between epinephrine and tramazoline during nasotracheal intubation: a double-blind randomized trial.

Aiji Sato-Boku, Yoshiki Sento, Yuji Kamimura...

https://pubmed.ncbi.nlm.nih.gov/34592949

North Polar Tube Reduces the Risk of Epistaxis during Nasotracheal Intubation: A prospective, Randomized Clinical Trial.

Ahmet Seli M Özkan, Sedat Akbas, Erol Toy...

https://pubmed.ncbi.nlm.nih.gov/30787962

Epistaxis during nasotracheal intubation: a randomized trial of the Parker Flex-Tip™ nasal endotracheal tube with a posterior facing bevel versus a standard nasal RAE endotracheal tube.

Rosie Earle, Enda Shanahan, Himat Vaghadia...

https://pubmed.ncbi.nlm.nih.gov/28078544

A prospective randomized trial of xylometazoline drops and epinephrine merocele nasal pack for reducing epistaxis during nasotracheal intubation.

Sonam Patel, Amarjyoti Hazarika, Prachi Agrawal...

https://pubmed.ncbi.nlm.nih.gov/32934988